Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Brazilian cities deny media reports that they used expired COVID-19 shots

Fri, 02nd Jul 2021 21:54

(New throughout, adds denials by cities)

BRASILIA, July 2 (Reuters) - Municipalities across Brazil on
Friday denied a newspaper report that said health ministry data
showed cities administered at least 26,000 expired AstraZeneca
COVID-19 vaccine shots.

The southern city of Maringá, cited in the Folha de S.Paulo
story as being the municipality to have used the most expired
shots (over 3,500), denied the allegation, saying the doses only
appeared to have expired on public databases due to a delay in
the registration of new data in the Health Ministry system.

"There were no expired vaccine doses in Maringá, but there
was an error in the system of (public health network) SUS," said
the city's Health Secretary Marcelo Puzzi in a statement. Other
cities blamed the confusion on the same data issue.

Local governments for the cities of São Paulo, Juiz de Fora
and Belo Horizonte, which were also mentioned in the Folha
story, issued statements denying having given out-of-date shots.

Brazil's vaccine rollout has faced widespread criticism. The
government was slow to buy vaccines, and is now dealing with an
alleged corruption scandal surrounding its procurement efforts.

Expired vaccine doses can be less effective. In Africa, a
number of countries have found themselves with batches that have
passed their shelf life sparking a debate over extending expiry
dates. In May, Malawi destroyed nearly 20,000 doses that had
expired.

Brazilian President Jair Bolsonaro has so far declined to
take a vaccine and has sowed doubts about inoculations, pushed
unproven miracle cures and underplayed the severity of a
pandemic that has killed over a half a million Brazilians.

According to the report, the expired vaccines came from
batches imported from India by the public Fiocruz biomedical
institute, or acquired through the Pan American Health
Organization (PAHO).

Neither the Health Ministry, Fiocruz nor PAHO immediately
responded to requests for comment. The Serum Institute of India,
which made the shots, also did not immediately reply.

The AstraZeneca vaccine is one of the two dominant COVID-19
shots in Brazil, alongside China's CoronaVac.
(Reporting by Ricardo Brito; additional reporting by Stephen
Eisenhammer; writing by Pedro Fonseca and Gabriel Stargardter;
Editing by Aurora Ellis and David Gregorio)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.